{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:02:40Z","timestamp":1781701360127,"version":"3.54.5"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T00:00:00Z","timestamp":1594598400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T00:00:00Z","timestamp":1594598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s11255-020-02563-2","type":"journal-article","created":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T09:03:31Z","timestamp":1594631011000},"page":"2311-2320","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Complications of metabolic acidosis and alkalinizing therapy in chronic kidney disease patients: a clinician-directed organ-specific primer"],"prefix":"10.1007","volume":"52","author":[{"given":"Sidar","family":"Copur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan A.","family":"Sag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baris","family":"Afsar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Rossignol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Covic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1297-0675","authenticated-orcid":false,"given":"Mehmet","family":"Kanbay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,13]]},"reference":[{"issue":"7","key":"2563_CR1","doi-asserted-by":"crossref","first-page":"e0158765","DOI":"10.1371\/journal.pone.0158765","volume":"11","author":"NR Hill","year":"2016","unstructured":"Hill NR, Fatoba ST, Oke JL, Hirst JA, O'Callaghan CA, Lasserson DS et al (2016) Global prevalence of chronic kidney disease\u2014a systematic review and meta-analysis. PLoS ONE 11(7):e0158765","journal-title":"PLoS ONE"},{"issue":"5","key":"2563_CR2","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/ki.2015.230","volume":"88","author":"KT Mills","year":"2015","unstructured":"Mills KT, Xu Y, Zhang W, Bundy JD, Chen CS, Kelly TN et al (2015) A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int 88(5):950\u2013957","journal-title":"Kidney Int"},{"issue":"6","key":"2563_CR3","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nrneph.2017.52","volume":"13","author":"C Zoccali","year":"2017","unstructured":"Zoccali C, Vanholder R, Massy ZA, Ortiz A, Sarafidis P, Dekker FW et al (2017) The systemic nature of CKD. Nat Rev Nephrol 13(6):344\u2013358","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"2563_CR4","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S2213-8587(16)00033-4","volume":"4","author":"R Vanholder","year":"2016","unstructured":"Vanholder R, Fouque D, Glorieux G, Heine GH, Kanbay M, Mallamaci F et al (2016) Clinical management of the uraemic syndrome in chronic kidney disease. Lancet Diabetes Endocrinol 4(4):360\u2013373","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"2563_CR5","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1053\/j.ajkd.2015.08.028","volume":"67","author":"JA Kraut","year":"2016","unstructured":"Kraut JA, Madias NE (2016) Metabolic acidosis of CKD: an update. Am J Kidney Dis 67(2):307\u2013317","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"2563_CR6","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.2215\/CJN.10120818","volume":"13","author":"MK Abramowitz","year":"2018","unstructured":"Abramowitz MK (2018) Metabolic acidosis and cardiovascular disease risk in CKD. Clin J Am Soc Nephrol 13(10):1451\u20131452","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"2563_CR7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1053\/j.ajkd.2019.01.036","volume":"74","author":"KL Raphael","year":"2019","unstructured":"Raphael KL (2019) Metabolic acidosis in CKD: core curriculum 2019. Am J Kidney Dis 74(2):263\u2013275","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"2563_CR8","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.2215\/CJN.13091118","volume":"14","author":"SD Navaneethan","year":"2019","unstructured":"Navaneethan SD, Shao J, Buysse J, Bushinsky DA (2019) Effects of treatment of metabolic acidosis in CKD: a systematic review and meta-analysis. Clin J Am Soc Nephrol 14(7):1011\u20131020","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"2563_CR9","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jcrc.2011.06.001","volume":"27","author":"E Crimi","year":"2012","unstructured":"Crimi E, Taccone FS, Infante T, Scolletta S, Crudele V, Napoli C (2012) Effects of intracellular acidosis on endothelial function: an overview. J Crit Care 27(2):108\u2013118","journal-title":"J Crit Care"},{"issue":"2","key":"2563_CR10","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.krcp.2015.05.003","volume":"34","author":"MS Goligorsky","year":"2015","unstructured":"Goligorsky MS (2015) Pathogenesis of endothelial cell dysfunction in chronic kidney disease: a retrospective and what the future may hold. Kidney Res Clin Pract 34(2):76\u201382","journal-title":"Kidney Res Clin Pract"},{"issue":"2","key":"2563_CR11","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1172\/JCI112020","volume":"76","author":"KA Nath","year":"1985","unstructured":"Nath KA, Hostetter MK, Hostetter TH (1985) Pathophysiology of chronic tubulo-interstitial disease in rats. Interactions of dietary acid load, ammonia, and complement component C3. J Clin Invest. 76(2):667\u2013675","journal-title":"J Clin Invest."},{"issue":"4","key":"2563_CR12","doi-asserted-by":"crossref","first-page":"F830","DOI":"10.1152\/ajprenal.00587.2010","volume":"300","author":"DE Wesson","year":"2011","unstructured":"Wesson DE, Simoni J, Broglio K, Sheather S (2011) Acid retention accompanies reduced GFR in humans and increases plasma levels of endothelin and aldosterone. Am J Physiol Renal Physiol 300(4):F830\u2013F837","journal-title":"Am J Physiol Renal Physiol"},{"issue":"7","key":"2563_CR13","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s11255-016-1271-6","volume":"48","author":"M Kanbay","year":"2016","unstructured":"Kanbay M, Afsar B, Siriopol D, Unal HU, Karaman M, Saglam M et al (2016) Relevance of uric acid and asymmetric dimethylarginine for modeling cardiovascular risk prediction in chronic kidney disease patients. Int Urol Nephrol 48(7):1129\u20131136","journal-title":"Int Urol Nephrol"},{"issue":"4","key":"2563_CR14","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1159\/000324847","volume":"33","author":"M Kanbay","year":"2011","unstructured":"Kanbay M, Yilmaz MI, Sonmez A, Turgut F, Saglam M, Cakir E et al (2011) Serum uric acid level and endothelial dysfunction in patients with nondiabetic chronic kidney disease. Am J Nephrol 33(4):298\u2013304","journal-title":"Am J Nephrol"},{"issue":"3","key":"2563_CR15","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s11255-009-9675-1","volume":"42","author":"M Kanbay","year":"2010","unstructured":"Kanbay M, Afsar B, Gusbeth-Tatomir P, Covic A (2010) Arterial stiffness in dialysis patients: where are we now? Int Urol Nephrol 42(3):741\u2013752","journal-title":"Int Urol Nephrol"},{"issue":"3","key":"2563_CR16","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/HJH.0000000000001599","volume":"36","author":"GP Rossi","year":"2018","unstructured":"Rossi GP, Seccia TM, Barton M, Danser AHJ, de Leeuw PW, Dhaun N et al (2018) Endothelial factors in the pathogenesis and treatment of chronic kidney disease Part I: general mechanisms: a joint consensus statement from the European Society of Hypertension Working Group on Endothelin and Endothelial Factors and The Japanese Society of Hypertension. J Hypertens 36(3):451\u2013461","journal-title":"J Hypertens"},{"issue":"3","key":"2563_CR17","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/HJH.0000000000001600","volume":"36","author":"GP Rossi","year":"2018","unstructured":"Rossi GP, Seccia TM, Barton M, Danser AHJ, de Leeuw PW, Dhaun N et al (2018) Endothelial factors in the pathogenesis and treatment of chronic kidney disease Part II: role in disease conditions: a joint consensus statement from the European Society of Hypertension Working Group on Endothelin and Endothelial Factors and the Japanese Society of Hypertension. J Hypertens 36(3):462\u2013471","journal-title":"J Hypertens"},{"issue":"7","key":"2563_CR18","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1161\/01.CIR.0000138745.21879.27","volume":"110","author":"F Perticone","year":"2004","unstructured":"Perticone F, Maio R, Tripepi G, Zoccali C (2004) Endothelial dysfunction and mild renal insufficiency in essential hypertension. Circulation 110(7):821\u2013825","journal-title":"Circulation"},{"issue":"2","key":"2563_CR19","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1523-1755.2003.00108.x","volume":"64","author":"E Mervaala","year":"2003","unstructured":"Mervaala E, Finckenberg P, Lapatto R, M\u00fcller DN, Park JK, Dechend R et al (2003) Lipoic acid supplementation prevents angiotensin II-induced renal injury. Kidney Int 64(2):501\u2013508","journal-title":"Kidney Int"},{"issue":"3","key":"2563_CR20","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1681\/ASN.2013050545","volume":"25","author":"J Himmelfarb","year":"2014","unstructured":"Himmelfarb J, Ikizler TA, Ellis C, Wu P, Shintani A, Dalal S et al (2014) Provision of antioxidant therapy in hemodialysis (PATH): a randomized clinical trial. J Am Soc Nephrol 25(3):623\u2013633","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"2563_CR21","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.2215\/CJN.00380118","volume":"13","author":"J Kendrick","year":"2018","unstructured":"Kendrick J, Shah P, Andrews E, You Z, Nowak K, Pasch A et al (2018) Effect of treatment of metabolic acidosis on vascular endothelial function in patients with CKD: a pilot randomized cross-over study. Clin J Am Soc Nephrol CJASN 13(10):1463\u20131470","journal-title":"Clin J Am Soc Nephrol CJASN"},{"issue":"1","key":"2563_CR22","first-page":"121","volume":"35","author":"AK Dubey","year":"2020","unstructured":"Dubey AK, Sahoo J, Vairappan B, Haridasan S, Parameswaran S, Priyamvada PS (2020) Correction of metabolic acidosis improves muscle mass and renal function in chronic kidney disease stages 3 and 4: a randomized controlled trial. Nephrol Dial Transplant 35(1):121\u2013129","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"2563_CR23","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s11255-016-1240-0","volume":"48","author":"AA Sag","year":"2016","unstructured":"Sag AA, Covic A, London G, Vervloet M, Goldsmith D, Gorriz JL et al (2016) Clinical imaging of vascular disease in chronic kidney disease. Int Urol Nephrol 48(6):827\u2013837","journal-title":"Int Urol Nephrol"},{"issue":"3","key":"2563_CR24","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00223-016-0206-7","volume":"100","author":"M Kanbay","year":"2017","unstructured":"Kanbay M, Vervloet M, Cozzolino M, Siriopol D, Covic A, Goldsmith D et al (2017) Novel faces of fibroblast growth factor 23 (FGF23): iron deficiency, inflammation, insulin resistance, left ventricular hypertrophy, proteinuria and acute kidney injury. Calcif Tissue Int 100(3):217\u2013228","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"2563_CR25","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.semnephrol.2018.02.004","volume":"38","author":"L H\u00e9naut","year":"2018","unstructured":"H\u00e9naut L, Chillon JM, Kamel S, Massy ZA (2018) Updates on the mechanisms and the care of cardiovascular calcification in chronic kidney disease. Semin Nephrol 38(3):233\u2013250","journal-title":"Semin Nephrol"},{"issue":"2","key":"2563_CR26","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000197562","volume":"27","author":"M Kanbay","year":"2009","unstructured":"Kanbay M, Goldsmith D, Akcay A, Covic A (2009) Phosphate - the silent stealthy cardiorenal culprit in all stages of chronic kidney disease: a systematic review. Blood Purif 27(2):220\u2013230","journal-title":"Blood Purif"},{"key":"2563_CR27","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3389\/fendo.2018.00207","volume":"9","author":"F Lang","year":"2018","unstructured":"Lang F, Leibrock C, Pelzl L, Gawaz M, Pieske B, Alesutan I et al (2018) therapeutic interference with vascular calcification-lessons from klotho-hypomorphic mice and beyond. Front Endocrinol (Lausanne) 9:207","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"2563_CR28","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1080\/10641963.2017.1384482","volume":"40","author":"S Zhang","year":"2018","unstructured":"Zhang S, Xu J, Feng Y, Zhang J, Cui L, Zhang H et al (2018) Extracellular acidosis suppresses calcification of vascular smooth muscle cells by inhibiting calcium influx via L-type calcium channels. Clin Exp Hypertens 40(4):370\u2013377","journal-title":"Clin Exp Hypertens"},{"issue":"4","key":"2563_CR29","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/sj.ki.5002646","volume":"73","author":"F Mendoza","year":"2008","unstructured":"Mendoza F, Lopez I, De Oca AM, Perez J, Rodriguez M, Aguilera-Tejero E (2008) Metabolic acidosis inhibits soft tissue calcification in uremic rats. Kidney Int 73(4):407\u2013414","journal-title":"Kidney Int"},{"issue":"8","key":"2563_CR30","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1038\/sj.ki.5000297","volume":"69","author":"K Lomashvili","year":"2006","unstructured":"Lomashvili K, Garg P, O\u2019neill W (2006) Chemical and hormonal determinants of vascular calcification in vitro. Kidney Int 69(8):1464\u20131470","journal-title":"Kidney Int"},{"issue":"3","key":"2563_CR31","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1681\/ASN.2016070780","volume":"28","author":"MK Abramowitz","year":"2017","unstructured":"Abramowitz MK (2017) Bicarbonate balance and prescription in ESRD. J Am Soc Nephrol 28(3):726\u2013734","journal-title":"J Am Soc Nephrol"},{"issue":"47","key":"2563_CR32","doi-asserted-by":"crossref","first-page":"e8802","DOI":"10.1097\/MD.0000000000008802","volume":"96","author":"C C\u0103pu\u015f\u0103","year":"2017","unstructured":"C\u0103pu\u015f\u0103 C, \u015etefan G, Stancu S, Lipan M, Tsur LD, Mircescu G (2017) Metabolic acidosis of chronic kidney disease and subclinical cardiovascular disease markers: friend or foe? Medicine (Baltimore) 96(47):e8802","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"2563_CR33","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1159\/000498975","volume":"44","author":"C Aigner","year":"2019","unstructured":"Aigner C, Cejka D, Sliber C, Fraunschiel M, Sunder-Plassmann G, Gaggl M (2019) Oral sodium bicarbonate supplementation does not affect serum calcification propensity in patients with chronic kidney disease and chronic metabolic acidosis. Kidney Blood Press Res 44(2):188\u2013199","journal-title":"Kidney Blood Press Res"},{"issue":"5","key":"2563_CR34","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/ki.1972.48","volume":"1","author":"JH Mitchell","year":"1972","unstructured":"Mitchell JH, Wildenthal K, Johnson RL Jr (1972) The effects of acid-base disturbances on cardiovascular and pulmonary function. Kidney Int 1(5):375\u2013389","journal-title":"Kidney Int"},{"issue":"2","key":"2563_CR35","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1164\/ajrccm.159.2.9802093","volume":"159","author":"A Pedoto","year":"1999","unstructured":"Pedoto A, Caruso JE, Nandi J, Oler A, Hoffmann SP, Tassiopoulos AK et al (1999) Acidosis stimulates nitric oxide production and lung damage in rats. Am J Respir Crit Care Med 159(2):397\u2013402","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl 1","key":"2563_CR36","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/SHK.0b013e3181818518","volume":"30","author":"D Fernandes","year":"2008","unstructured":"Fernandes D, Assreuy J (2008) Nitric oxide and vascular reactivity in sepsis. Shock 30(Suppl 1):10\u201313","journal-title":"Shock"},{"issue":"4","key":"2563_CR37","first-page":"267","volume":"13","author":"S Stancu","year":"2018","unstructured":"Stancu S, Mircescu G, Mocanu A, Capusa C, Stefan G (2018) Metabolic acidosis of chronic kidney disease and cardiovascular disorders. Maedica 13(4):267\u2013272","journal-title":"Maedica"},{"issue":"2","key":"2563_CR38","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1161\/HYPERTENSIONAHA.107.092643","volume":"50","author":"EN Taylor","year":"2007","unstructured":"Taylor EN, Forman JP, Farwell WR (2007) Serum anion gap and blood pressure in the national health and nutrition examination survey. Hypertension 50(2):320\u2013324","journal-title":"Hypertension"},{"issue":"3","key":"2563_CR39","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000328037","volume":"32","author":"MI Yilmaz","year":"2011","unstructured":"Yilmaz MI, Solak Y, Covic A, Goldsmith D, Kanbay M (2011) Renal anemia of inflammation: the name is self-explanatory. Blood Purif 32(3):220\u2013225","journal-title":"Blood Purif"},{"issue":"Suppl 1","key":"2563_CR40","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1681\/ASN.2004110972","volume":"16","author":"G Tripepi","year":"2005","unstructured":"Tripepi G, Mallamaci F, Zoccali C (2005) Inflammation markers, adhesion molecules, and all-cause and cardiovascular mortality in patients with ESRD: searching for the best risk marker by multivariate modeling. J Am Soc Nephrol 16(Suppl 1):S83\u2013S88","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"2563_CR41","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1053\/j.ajkd.2005.09.014","volume":"47","author":"H Honda","year":"2006","unstructured":"Honda H, Qureshi AR, Heimb\u00fcrger O, Barany P, Wang K, Pecoits-Filho R et al (2006) Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis 47(1):139\u2013148","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"2563_CR42","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.2215\/CJN.03500412","volume":"7","author":"J Gupta","year":"2012","unstructured":"Gupta J, Mitra N, Kanetsky PA, Devaney J, Wing MR, Reilly M et al (2012) Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC. Clin J Am Soc Nephrol 7(12):1938\u20131946","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"2563_CR43","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s11255-018-1873-2","volume":"50","author":"M Kanbay","year":"2018","unstructured":"Kanbay M, Onal EM, Afsar B, Dagel T, Yerlikaya A, Covic A et al (2018) The crosstalk of gut microbiota and chronic kidney disease: role of inflammation, proteinuria, hypertension, and diabetes mellitus. Int Urol Nephrol 50(8):1453\u20131466","journal-title":"Int Urol Nephrol"},{"issue":"2","key":"2563_CR44","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41440-018-0144-z","volume":"42","author":"EM Onal","year":"2019","unstructured":"Onal EM, Afsar B, Covic A, Vaziri ND, Kanbay M (2019) Gut microbiota and inflammation in chronic kidney disease and their roles in the development of cardiovascular disease. Hypertens Res 42(2):123\u2013140","journal-title":"Hypertens Res"},{"issue":"10","key":"2563_CR45","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.4049\/jimmunol.1701605","volume":"200","author":"SC Ray","year":"2018","unstructured":"Ray SC, Baban B, Tucker MA, Seaton AJ, Chang KC, Mannon EC et al (2018) Oral NaHCO(3) activates a splenic anti-inflammatory pathway: evidence that cholinergic signals are transmitted via mesothelial cells. J Immunol 200(10):3568\u20133586","journal-title":"J Immunol"},{"key":"2563_CR46","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.biopha.2015.02.012","volume":"71","author":"Y Ori","year":"2015","unstructured":"Ori Y, Zingerman B, Bergman M, Bessler H, Salman H (2015) The effect of sodium bicarbonate on cytokine secretion in CKD patients with metabolic acidosis. Biomed Pharmacother 71:98\u2013101","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"2563_CR47","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","volume":"79","author":"T Isakova","year":"2011","unstructured":"Isakova T, Wahl P, Vargas GS, Guti\u00e9rrez OM, Scialla J, Xie H et al (2011) Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int 79(12):1370\u20131378","journal-title":"Kidney Int"},{"issue":"11","key":"2563_CR48","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","volume":"121","author":"C Faul","year":"2011","unstructured":"Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, Isakova T et al (2011) FGF23 induces left ventricular hypertrophy. J Clin Invest 121(11):4393\u20134408","journal-title":"J Clin Invest"},{"issue":"4","key":"2563_CR49","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1053\/j.ackd.2016.03.008","volume":"23","author":"ML Melamed","year":"2016","unstructured":"Melamed ML, Buttar RS, Coco M (2016) CKD-mineral bone disorder in stage 4 and 5 CKD: what we know today? Adv Chron Kidney Dis 23(4):262\u2013269","journal-title":"Adv Chron Kidney Dis"},{"issue":"1","key":"2563_CR50","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2215\/CJN.03050608","volume":"4","author":"P Muntner","year":"2009","unstructured":"Muntner P, Jones TM, Hyre AD, Melamed ML, Alper A, Raggi P et al (2009) Association of serum intact parathyroid hormone with lower estimated glomerular filtration rate. Clin J Am Soc Nephrol 4(1):186\u2013194","journal-title":"Clin J Am Soc Nephrol"},{"key":"2563_CR51","unstructured":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2009(113):S1\u2013130"},{"issue":"6","key":"2563_CR52","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/MPA.0b013e3181a9d5af","volume":"38","author":"M Al-Haddad","year":"2009","unstructured":"Al-Haddad M, Khashab M, Zyromski N, Pungpapong S, Wallace MB, Scolapio J et al (2009) Risk factors for hyperechogenic pancreas on endoscopic ultrasound: a case-control study. Pancreas 38(6):672\u2013675","journal-title":"Pancreas"},{"issue":"8","key":"2563_CR53","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","volume":"15","author":"GA Block","year":"2004","unstructured":"Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM (2004) Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15(8):2208\u20132218","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"2563_CR54","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","volume":"71","author":"A Levin","year":"2007","unstructured":"Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA et al (2007) Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 71(1):31\u201338","journal-title":"Kidney Int"},{"issue":"9","key":"2563_CR55","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.2215\/CJN.02640311","volume":"6","author":"IH de Boer","year":"2011","unstructured":"de Boer IH, Katz R, Chonchol M, Ix JH, Sarnak MJ, Shlipak MG et al (2011) Serum 25-hydroxyvitamin D and change in estimated glomerular filtration rate. Clin J Am Soc Nephrol 6(9):2141\u20132149","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"2563_CR56","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1053\/j.ajkd.2015.08.026","volume":"67","author":"CM Rebholz","year":"2016","unstructured":"Rebholz CM, Grams ME, Lutsey PL, Hoofnagle AN, Misialek JR, Inker LA et al (2016) Biomarkers of vitamin D status and risk of ESRD. Am J Kidney Dis 67(2):235\u2013242","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"2563_CR57","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2215\/CJN.03940510","volume":"6","author":"P Kandula","year":"2011","unstructured":"Kandula P, Dobre M, Schold JD, Schreiber MJ Jr, Mehrotra R, Navaneethan SD (2011) Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials. Clin J Am Soc Nephrol 6(1):50\u201362","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"2563_CR58","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.ahj.2012.09.018","volume":"164","author":"H Tamez","year":"2012","unstructured":"Tamez H, Zoccali C, Packham D, Wenger J, Bhan I, Appelbaum E et al (2012) Vitamin D reduces left atrial volume in patients with left ventricular hypertrophy and chronic kidney disease. Am Heart J 164(6):902\u20139.e2","journal-title":"Am Heart J"},{"issue":"1","key":"2563_CR59","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1681\/ASN.2013010103","volume":"25","author":"AY Wang","year":"2014","unstructured":"Wang AY, Fang F, Chan J, Wen YY, Qing S, Chan IH et al (2014) Effect of paricalcitol on left ventricular mass and function in CKD\u2014the OPERA trial. J Am Soc Nephrol 25(1):175\u2013186","journal-title":"J Am Soc Nephrol"},{"key":"2563_CR60","doi-asserted-by":"crossref","unstructured":"Banerjee D, Chitalia N, Ster IC, Appelbaum E, Thadhani R, Kaski JC et al (2019) Impact of Vitamin D on Cardiac structure and function in CKD patients with hypovitaminosis D, a randomised controlled trial and meta-analysis. Eur Heart J Cardiovasc Pharmacother","DOI":"10.1093\/ehjcvp\/pvz080"},{"issue":"7","key":"2563_CR61","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2012.120","volume":"307","author":"R Thadhani","year":"2012","unstructured":"Thadhani R, Appelbaum E, Pritchett Y, Chang Y, Wenger J, Tamez H et al (2012) Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial. JAMA 307(7):674\u2013684","journal-title":"JAMA"},{"issue":"1","key":"2563_CR62","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1053\/j.ajkd.2005.04.013","volume":"46","author":"C Charytan","year":"2005","unstructured":"Charytan C, Coburn JW, Chonchol M, Herman J, Lien YH, Liu W et al (2005) Cinacalcet hydrochloride is an effective treatment for secondary hyperparathyroidism in patients with CKD not receiving dialysis. Am J Kidney Dis 46(1):58\u201367","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"2563_CR63","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1053\/j.ajkd.2008.09.021","volume":"53","author":"M Chonchol","year":"2009","unstructured":"Chonchol M, Locatelli F, Abboud HE, Charytan C, de Francisco AL, Jolly S et al (2009) A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet HCl in participants with CKD not receiving dialysis. Am J Kidney Dis 53(2):197\u2013207","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"2563_CR64","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1681\/ASN.2008060609","volume":"20","author":"T Isakova","year":"2009","unstructured":"Isakova T, Guti\u00e9rrez OM, Chang Y, Shah A, Tamez H, Smith K et al (2009) Phosphorus binders and survival on hemodialysis. J Am Soc Nephrol 20(2):388\u2013396","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"2563_CR65","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1681\/ASN.2012030223","volume":"23","author":"GA Block","year":"2012","unstructured":"Block GA, Wheeler DC, Persky MS, Kestenbaum B, Ketteler M, Spiegel DM et al (2012) Effects of phosphate binders in moderate CKD. J Am Soc Nephrol 23(8):1407\u20131415","journal-title":"J Am Soc Nephrol"},{"issue":"9900","key":"2563_CR66","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0140-6736(13)60897-1","volume":"382","author":"SA Jamal","year":"2013","unstructured":"Jamal SA, Vandermeer B, Raggi P, Mendelssohn DC, Chatterley T, Dorgan M et al (2013) Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis. Lancet 382(9900):1268\u20131277","journal-title":"Lancet"},{"issue":"3 Pt 2","key":"2563_CR67","first-page":"F442","volume":"262","author":"NS Krieger","year":"1992","unstructured":"Krieger NS, Sessler NE, Bushinsky DA (1992) Acidosis inhibits osteoblastic and stimulates osteoclastic activity in vitro. Am J Physiol 262(3 Pt 2):F442\u2013F448","journal-title":"Am J Physiol"},{"issue":"5","key":"2563_CR68","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/ki.1986.242","volume":"30","author":"JA Kraut","year":"1986","unstructured":"Kraut JA, Mishler DR, Singer FR, Goodman WG (1986) The effects of metabolic acidosis on bone formation and bone resorption in the rat. Kidney Int 30(5):694\u2013700","journal-title":"Kidney Int"},{"issue":"4","key":"2563_CR69","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1046\/j.1525-139x.2000.00070.x","volume":"13","author":"JA Kraut","year":"2000","unstructured":"Kraut JA (2000) Disturbances of acid-base balance and bone disease in end-stage renal disease. Semin Dial 13(4):261\u2013266","journal-title":"Semin Dial"},{"issue":"3","key":"2563_CR70","doi-asserted-by":"crossref","first-page":"M440","DOI":"10.1097\/00002480-199407000-00038","volume":"40","author":"YF Lin","year":"1994","unstructured":"Lin YF, Shieh SD, Diang LK, Lin SH, Chyr SH, Li BL et al (1994) Influence of rapid correction of metabolic acidosis on serum osteocalcin level in chronic renal failure. Asaio J 40(3):M440\u2013M444","journal-title":"Asaio J"},{"issue":"1","key":"2563_CR71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08860220500461187","volume":"28","author":"RP Mathur","year":"2006","unstructured":"Mathur RP, Dash SC, Gupta N, Prakash S, Saxena S, Bhowmik D (2006) Effects of correction of metabolic acidosis on blood urea and bone metabolism in patients with mild to moderate chronic kidney disease: a prospective randomized single blind controlled trial. Ren Fail 28(1):1\u20135","journal-title":"Ren Fail"},{"issue":"2","key":"2563_CR72","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1172\/JCI108962","volume":"61","author":"E McSherry","year":"1978","unstructured":"McSherry E, Morris RC Jr (1978) Attainment and maintenance of normal stature with alkali therapy in infants and children with classic renal tubular acidosis. J Clin Invest 61(2):509\u2013527","journal-title":"J Clin Invest"},{"issue":"4","key":"2563_CR73","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1056\/NEJM199407283310421","volume":"331","author":"A Sebastian","year":"1994","unstructured":"Sebastian A, Morris RC Jr (1994) Improved mineral balance and skeletal metabolism in postmenopausal women treated with potassium bicarbonate. N Engl J Med 331(4):279","journal-title":"N Engl J Med"},{"issue":"8","key":"2563_CR74","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1097\/01.ASN.0000023433.08833.88","volume":"13","author":"FE Karet","year":"2002","unstructured":"Karet FE (2002) Inherited distal renal tubular acidosis. J Am Soc Nephrol 13(8):2178\u20132184","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"2563_CR75","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1471-2369-13-66","volume":"13","author":"S Karunarathne","year":"2012","unstructured":"Karunarathne S, Udayakumara Y, Govindapala D, Fernando H (2012) Medullary nephrocalcinosis, distal renal tubular acidosis and polycythaemia in a patient with nephrotic syndrome. BMC Nephrol 13(1):66","journal-title":"BMC Nephrol"},{"issue":"8","key":"2563_CR76","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00296-014-2993-3","volume":"34","author":"T Both","year":"2014","unstructured":"Both T, Zietse R, Hoorn EJ, van Hagen PM, Dalm VA, van Laar JA et al (2014) Everything you need to know about distal renal tubular acidosis in autoimmune disease. Rheumatol Int 34(8):1037\u20131045","journal-title":"Rheumatol Int"},{"issue":"11","key":"2563_CR77","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s40265-017-0758-5","volume":"77","author":"WLS Peter","year":"2017","unstructured":"Peter WLS, Wazny LD, Weinhandl E, Cardone KE, Hudson JQ (2017) A review of phosphate binders in chronic kidney disease: incremental progress or just higher costs? Drugs 77(11):1155\u20131186","journal-title":"Drugs"},{"issue":"9","key":"2563_CR78","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/sj.ki.5002466","volume":"72","author":"WN Suki","year":"2007","unstructured":"Suki WN, Zabaneh R, Cangiano J, Reed J, Fischer D, Garrett L et al (2007) Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients. Kidney Int 72(9):1130\u20131137","journal-title":"Kidney Int"},{"issue":"3","key":"2563_CR79","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000101827","volume":"27","author":"RN Foley","year":"2007","unstructured":"Foley RN, Wang C, Ishani A, Collins AJ, Murray AM (2007) Kidney function and sarcopenia in the United States general population: NHANES III. Am J Nephrol 27(3):279\u2013286","journal-title":"Am J Nephrol"},{"issue":"1","key":"2563_CR80","doi-asserted-by":"crossref","first-page":"98","DOI":"10.5935\/0101-2800.20150014","volume":"37","author":"VA Souza","year":"2015","unstructured":"Souza VA, Oliveira D, Mansur HN, Fernandes NM, Bastos MG (2015) Sarcopenia in chronic kidney disease. J Bras Nefrol 37(1):98\u2013105","journal-title":"J Bras Nefrol"},{"issue":"4","key":"2563_CR81","doi-asserted-by":"crossref","first-page":"1128S","DOI":"10.3945\/ajcn.2010.28608B","volume":"91","author":"BT Workeneh","year":"2010","unstructured":"Workeneh BT, Mitch WE (1128S) Review of muscle wasting associated with chronic kidney disease. Am J Clin Nutr 91(4):1128S\u2013S1132","journal-title":"Am J Clin Nutr"},{"key":"2563_CR82","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.nut.2018.12.005","volume":"62","author":"S Lai","year":"2019","unstructured":"Lai S, Muscaritoli M, Andreozzi P, Sgreccia A, De Leo S, Mazzaferro S et al (2019) Sarcopenia and cardiovascular risk indices in patients with chronic kidney disease on conservative and replacement therapy. Nutrition 62:108\u2013114","journal-title":"Nutrition"},{"issue":"1","key":"2563_CR83","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1053\/j.ajkd.2010.12.021","volume":"58","author":"MK Abramowitz","year":"2011","unstructured":"Abramowitz MK, Hostetter TH, Melamed ML (2011) Association of serum bicarbonate levels with gait speed and quadriceps strength in older adults. Am J Kidney Dis 58(1):29\u201338","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"2563_CR84","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/ki.2011.479","volume":"81","author":"MK Abramowitz","year":"2012","unstructured":"Abramowitz MK, Hostetter TH, Melamed ML (2012) Lower serum bicarbonate and a higher anion gap are associated with lower cardiorespiratory fitness in young adults. Kidney Int 81(10):1033\u20131042","journal-title":"Kidney Int"},{"issue":"9","key":"2563_CR85","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nrneph.2014.112","volume":"10","author":"XH Wang","year":"2014","unstructured":"Wang XH, Mitch WE (2014) Mechanisms of muscle wasting in chronic kidney disease. Nat Rev Nephrol 10(9):504\u2013516","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"2563_CR86","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S0272-6386(99)70059-4","volume":"34","author":"LL Hamm","year":"1999","unstructured":"Hamm LL (1999) Role of glucocorticoids in acidosis. Am J Kidney Dis 34(5):960\u2013965","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"2563_CR87","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.kint.2016.02.033","volume":"90","author":"J Esche","year":"2016","unstructured":"Esche J, Shi L, S\u00e1nchez-Guijo A, Hartmann MF, Wudy SA, Remer T (2016) Higher diet-dependent renal acid load associates with higher glucocorticoid secretion and potentially bioactive free glucocorticoids in healthy children. Kidney Int 90(2):325\u2013333","journal-title":"Kidney Int"},{"issue":"4","key":"2563_CR88","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1046\/j.1523-1755.2002.00276.x","volume":"61","author":"WP Pickering","year":"2002","unstructured":"Pickering WP, Price SR, Bircher G, Marinovic AC, Mitch WE, Walls J (2002) Nutrition in CAPD: serum bicarbonate and the ubiquitin-proteasome system in muscle. Kidney Int 61(4):1286\u20131292","journal-title":"Kidney Int"},{"issue":"4","key":"2563_CR89","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/ki.1997.433","volume":"52","author":"A Stein","year":"1997","unstructured":"Stein A, Moorhouse J, Iles-Smith H, Baker F, Johnstone J, James G et al (1997) Role of an improvement in acid-base status and nutrition in CAPD patients. Kidney Int 52(4):1089\u20131095","journal-title":"Kidney Int"},{"issue":"4","key":"2563_CR90","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1053\/jren.2002.35298","volume":"12","author":"C Verove","year":"2002","unstructured":"Verove C, Maisonneuve N, El Azouzi A, Boldron A, Azar R (2002) Effect of the correction of metabolic acidosis on nutritional status in elderly patients with chronic renal failure. J Renal Nutr 12(4):224\u2013228","journal-title":"J Renal Nutr"},{"issue":"9","key":"2563_CR91","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1681\/ASN.2008111205","volume":"20","author":"I de Brito-Ashurst","year":"2009","unstructured":"de Brito-Ashurst I, Varagunam M, Raftery MJ, Yaqoob MM (2009) Bicarbonate supplementation slows progression of CKD and improves nutritional status. J Am Soc Nephrol 20(9):2075\u20132084","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"2563_CR92","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.2215\/CJN.10371014","volume":"9","author":"MK Abramowitz","year":"2014","unstructured":"Abramowitz MK (2014) Acid-base balance and physical function. Clin J Am Soc Nephrol 9(12):2030\u20132032","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"2563_CR93","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1007\/s00421-013-2628-5","volume":"113","author":"EL Watson","year":"2013","unstructured":"Watson EL, Kosmadakis GC, Smith AC, Viana JL, Brown JR, Molyneux K et al (2013) Combined walking exercise and alkali therapy in patients with CKD4-5 regulates intramuscular free amino acid pools and ubiquitin E3 ligase expression. Eur J Appl Physiol 113(8):2111\u20132124","journal-title":"Eur J Appl Physiol"},{"issue":"Supplement","key":"2563_CR94","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.3177\/jnsv.61.S125","volume":"61","author":"Y Makanae","year":"2015","unstructured":"Makanae Y, Fujita S (2015) Role of exercise and nutrition in the prevention of sarcopenia. J Nutr Sci Vitaminol 61(Supplement):S125\u2013S127","journal-title":"J Nutr Sci Vitaminol"},{"issue":"1","key":"2563_CR95","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/jpm10010019","volume":"10","author":"A Maykish","year":"2020","unstructured":"Maykish A, Sikalidis AK (2020) Utilization of hydroxyl-methyl butyrate, leucine, glutamine and arginine supplementation in nutritional management of sarcopenia\u2014implications and clinical considerations for Type 2 diabetes mellitus risk modulation. J Person Med 10(1):19","journal-title":"J Person Med"},{"issue":"5","key":"2563_CR96","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1046\/j.1523-1755.1998.00898.x","volume":"53","author":"D Fliser","year":"1998","unstructured":"Fliser D, Pacini G, Engelleiter R, Kautzky-Willer A, Prager R, Franek E et al (1998) Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int 53(5):1343\u20131347","journal-title":"Kidney Int"},{"issue":"6","key":"2563_CR97","doi-asserted-by":"crossref","first-page":"F1087","DOI":"10.1152\/ajprenal.00340.2016","volume":"311","author":"B Spoto","year":"2016","unstructured":"Spoto B, Pisano A, Zoccali C (2016) Insulin resistance in chronic kidney disease: a systematic review. Am J Physiol Renal Physiol 311(6):F1087\u2013F1108","journal-title":"Am J Physiol Renal Physiol"},{"key":"2563_CR98","first-page":"691369","volume":"2012","author":"MT Liao","year":"2012","unstructured":"Liao MT, Sung CC, Hung KC, Wu CC, Lo L, Lu KC (2012) Insulin resistance in patients with chronic kidney disease. J Biomed Biotechnol 2012:691369","journal-title":"J Biomed Biotechnol"},{"issue":"9","key":"2563_CR99","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1093\/ndt\/gfq817","volume":"26","author":"M Landau","year":"2011","unstructured":"Landau M, Kurella-Tamura M, Shlipak MG, Kanaya A, Strotmeyer E, Koster A et al (2011) Correlates of insulin resistance in older individuals with and without kidney disease. Nephrol Dial Transplant 26(9):2814\u20132819","journal-title":"Nephrol Dial Transplant"},{"issue":"7315","key":"2563_CR100","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S0140-6736(63)90670-6","volume":"2","author":"BG Walker","year":"1963","unstructured":"Walker BG, Phear DN, Martin FI, Baird CW (1963) inhibition of insulin by acidosis. Lancet 2(7315):964\u2013965","journal-title":"Lancet"},{"issue":"32","key":"2563_CR101","doi-asserted-by":"crossref","first-page":"14951","DOI":"10.1016\/S0021-9258(18)66810-3","volume":"261","author":"Y Shechter","year":"1986","unstructured":"Shechter Y, Ron A (1986) Effect of depletion of bicarbonate or phosphate ions on insulin action in rat adipocytes. Further characterization of the receptor-effector system. J Biol Chem. 261(32):14951\u20134","journal-title":"J Biol Chem."},{"issue":"2","key":"2563_CR102","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1053\/j.ajkd.2004.09.034","volume":"45","author":"S Kobayashi","year":"2005","unstructured":"Kobayashi S, Maesato K, Moriya H, Ohtake T, Ikeda T (2005) Insulin resistance in patients with chronic kidney disease. Am J Kidney Dis 45(2):275\u2013280","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"2563_CR103","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/ndt\/15.1.65","volume":"15","author":"S Kobayashi","year":"2000","unstructured":"Kobayashi S, Maejima S, Ikeda T, Nagase M (2000) Impact of dialysis therapy on insulin resistance in end-stage renal disease: comparison of haemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 15(1):65\u201370","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"2563_CR104","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12882-016-0372-x","volume":"17","author":"A Bellasi","year":"2016","unstructured":"Bellasi A, Di Micco L, Santoro D, Marzocco S, De Simone E, Cozzolino M et al (2016) Correction of metabolic acidosis improves insulin resistance in chronic kidney disease. BMC Nephrol 17(1):158","journal-title":"BMC Nephrol"},{"issue":"2","key":"2563_CR105","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1053\/j.ajkd.2013.06.017","volume":"63","author":"W Chen","year":"2014","unstructured":"Chen W, Abramowitz MK (2014) Treatment of metabolic acidosis in patients with CKD. Am J Kidney Dis 63(2):311\u2013317","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"2563_CR106","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/ki.2010.129","volume":"78","author":"A Mahajan","year":"2010","unstructured":"Mahajan A, Simoni J, Sheather SJ, Broglio KR, Rajab MH, Wesson DE (2010) Daily oral sodium bicarbonate preserves glomerular filtration rate by slowing its decline in early hypertensive nephropathy. Kidney Int 78(3):303\u2013309","journal-title":"Kidney Int"},{"issue":"5","key":"2563_CR107","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1053\/j.ackd.2017.08.003","volume":"24","author":"W Chen","year":"2017","unstructured":"Chen W, Abramowitz MK (2017) Epidemiology of acid-base derangements in CKD. Adv Chron Kidney Dis 24(5):280\u2013288","journal-title":"Adv Chron Kidney Dis"},{"issue":"6","key":"2563_CR108","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0272-6386(00)70041-2","volume":"35","author":"B Kirschbaum","year":"2000","unstructured":"Kirschbaum B (2000) Spurious metabolic acidosis in hemodialysis patients. Am J Kidney Dis 35(6):1068\u20131071","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"2563_CR109","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/ki.2014.83","volume":"86","author":"N Goraya","year":"2014","unstructured":"Goraya N, Simoni J, Jo CH, Wesson DE (2014) Treatment of metabolic acidosis in patients with stage 3 chronic kidney disease with fruits and vegetables or oral bicarbonate reduces urine angiotensinogen and preserves glomerular filtration rate. Kidney Int 86(5):1031\u20131038","journal-title":"Kidney Int"},{"issue":"1","key":"2563_CR110","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/ki.2011.313","volume":"81","author":"N Goraya","year":"2012","unstructured":"Goraya N, Simoni J, Jo C, Wesson DE (2012) Dietary acid reduction with fruits and vegetables or bicarbonate attenuates kidney injury in patients with a moderately reduced glomerular filtration rate due to hypertensive nephropathy. Kidney Int 81(1):86\u201393","journal-title":"Kidney Int"},{"issue":"3","key":"2563_CR111","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2215\/CJN.02430312","volume":"8","author":"N Goraya","year":"2013","unstructured":"Goraya N, Simoni J, Jo CH, Wesson DE (2013) A comparison of treating metabolic acidosis in CKD stage 4 hypertensive kidney disease with fruits and vegetables or sodium bicarbonate. Clin J Am Soc Nephrol 8(3):371\u2013381","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-020-02563-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-020-02563-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-020-02563-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T00:03:01Z","timestamp":1626134581000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-020-02563-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,13]]},"references-count":111,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2563"],"URL":"https:\/\/doi.org\/10.1007\/s11255-020-02563-2","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,13]]},"assertion":[{"value":"19 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}